OR WAIT null SECS
An FDA inspection of compound pharmacy Innoveix Pharmaceuticals indicated these lots may not be sterile.
Innoveix Pharmaceuticals, a compounding pharmacy in Addison, Tex., is voluntarily recalling several lots of compounded drug products. The products are being recalled due to a lack of assurance of sterility. The issues where discovered during a routine inspection by the FDA.
The affected products are injectable sermorelin/ipamorelin 3mg and injectable AOD-9604 3mg. Sermorelin and ipamorelin are human growth hormone secretagogues (GHSs), which are compounds that increase growth hormone release. AOD is a synthetic peptide thought to have potential for weight loss.
To date, Innoveix Pharmaceuticals has not received any reports of adverse events related to this recall.
Sermorelin / Ipamorelin 3mg